# Satya Marar

Meilleurs épisodes de podcast
Actualisé:

Ep. 15: Satya Marar │ A Global Perspective on Individual Liberty

Stay in the know by following us on social media:https://twitter.com/AtlasNetworkhttps://www.instagram.com/atlasnetwork/https://www.facebook.com/atlasnetwork/Support the Atlas Network Mission Today: https://www.atlasnetwork.org/donate

The Bullpen REPLAY: Will Russian Sanctions Do Anything?

Satya Marar, tech writer and conservative policy analyst, enters The Bullpen to discuss sanctions on Russia with Dr. Rashad Richey on Indisputable. Debate Guest: Satya Marar  ***  Indisputable, features Dr. Richey talking about the top news stories of the day, reading viewer comments, and engaging …

The Brian Nichols Show: Why Are Medicine Prices So High in America?

Is the war on PBMs really about helping patients - or just another power grab dressed up as reform? In this eye-opening episode of The Brian Nichols Show, we rip the mask off the growing crusade against pharmacy benefit managers (PBMs). Critics claim PBMs are behind rising drug costs, but is that …

992: Why Are Medicine Prices So High in America?

In this eye-opening episode of The Brian Nichols Show, we rip the mask off the growing crusade against pharmacy benefit managers (PBMs). Critics claim PBMs are behind rising drug costs, but is that the full story - or just the version Big Pharma wants you to believe? If you’ve ever looked at your p…

992: Why Are Medicine Prices So High in America?

In this eye-opening episode of The Brian Nichols Show, we rip the mask off the growing crusade against pharmacy benefit managers (PBMs). Critics claim PBMs are behind rising drug costs, but is that the full story - or just the version Big Pharma wants you to believe? If you’ve ever looked at your p…

Satya Marar: How Cheap GLP-1s Could Save Lives — AND Kill Pharma Innovation

The era of GLP-1 weight-loss therapies has erupted into a high-stakes showdown: major drugmakers are slashing sticker prices while regulators grapple with mounting safety and access concerns. Just recently, Wegovy and Ozempic manufacturers announced a 30% cash-price reduction for uninsured American…

2026 Apr 21 Moving Forward with Young Voices

Expanding broadband coverage to rural customers is not as easy as it sounds. Satya Marar explains why getting the bureaucracy out of broadband is essential.   After 16 years under Viktor Orbán, Hungary is standing at a crossroads. Máté Hajba says the U.S. would be wise to seize upon that opportunit…

When Should We Recognize Something as a Property Right?

America has historically led the way in intangible property rights. We were the first country to recognize copyright and patents in our constitution and became the first to recognize trade secrets as protectable assets in 1868. Property rules assume that the rights-holder has superior knowledge abo…

When Should We Recognize Something as a Property Right?

America has historically led the way in intangible property rights. We were the first country to recognize copyright and patents in our constitution and became the first to recognize trade secrets as protectable assets in 1868. Property rules assume that the rights-holder has superior knowledge abo…

Right Diagnosis, Wrong Cure: Examining the True Cost of Drug Price Controls

In this episode, Mercatus Research Fellow Satya Marar speaks with Tomas Philipson, former Acting Chair of the Council of Economic Advisers and Professor at the University of Chicago, about the evidence behind drug price controls and their effects on healthcare affordability, pharmaceutical innovati…